CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSINI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.243
NA - Nord America 12.950
AS - Asia 4.212
SA - Sud America 55
OC - Oceania 20
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 15
Totale 30.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.908
GB - Regno Unito 5.125
CN - Cina 3.202
IT - Italia 1.604
FR - Francia 1.157
SE - Svezia 1.071
DE - Germania 1.048
IE - Irlanda 1.042
RU - Federazione Russa 846
FI - Finlandia 760
SG - Singapore 539
UA - Ucraina 269
TR - Turchia 139
JP - Giappone 108
BE - Belgio 68
VN - Vietnam 68
NL - Olanda 67
CA - Canada 37
KR - Corea 37
RO - Romania 37
ES - Italia 34
IN - India 34
IR - Iran 28
AT - Austria 27
BR - Brasile 24
HK - Hong Kong 20
AU - Australia 16
CL - Cile 14
CH - Svizzera 11
PL - Polonia 11
CZ - Repubblica Ceca 8
EU - Europa 8
PT - Portogallo 8
SK - Slovacchia (Repubblica Slovacca) 8
ZA - Sudafrica 8
GR - Grecia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BG - Bulgaria 6
IL - Israele 6
HR - Croazia 5
QA - Qatar 5
AR - Argentina 4
EG - Egitto 4
LV - Lettonia 4
MX - Messico 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
DK - Danimarca 3
EC - Ecuador 3
MA - Marocco 3
PE - Perù 3
PH - Filippine 3
SI - Slovenia 3
BD - Bangladesh 2
CO - Colombia 2
ID - Indonesia 2
IQ - Iraq 2
LK - Sri Lanka 2
MK - Macedonia 2
MN - Mongolia 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CU - Cuba 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
PK - Pakistan 1
PY - Paraguay 1
SC - Seychelles 1
SM - San Marino 1
TH - Thailandia 1
TW - Taiwan 1
Totale 30.512
Salva come PNG Salva come JPEG
Città #
Southend 4.797
Jacksonville 2.246
Chandler 2.205
Woodbridge 1.244
Dublin 1.026
Ann Arbor 959
Houston 671
Ashburn 665
Beijing 530
Lawrence 448
Princeton 448
Wilmington 424
Singapore 349
Jinan 325
Nanjing 294
Shenyang 277
New York 247
Redmond 238
Verona 214
Bologna 203
Sindelfingen 179
Hebei 175
Helsinki 171
Tianjin 146
Milan 137
Changsha 132
Ningbo 112
Haikou 110
Boardman 106
Nanchang 105
Zhengzhou 102
Tokyo 94
Jiaxing 87
Hangzhou 83
Taizhou 83
Redwood City 72
Seattle 68
Taiyuan 67
Norwalk 65
Brussels 61
Guangzhou 59
Washington 56
Falls Church 51
Rome 49
Fairfield 48
Lanzhou 43
Los Angeles 43
Dearborn 42
Fuzhou 42
Dong Ket 41
Orani 40
San Francisco 39
Chicago 31
Düsseldorf 31
Seoul 27
Groningen 25
Vienna 25
Detroit 24
Dongguan 23
Cagliari 22
Lancaster 22
Sanayi 20
Kent 18
Nürnberg 18
Toronto 18
Venice 18
Amsterdam 17
Esslingen am Neckar 16
Lappeenranta 16
Menlo Park 16
Moscow 16
Torino 16
Frankfurt am Main 14
Paris 14
Hong Kong 13
Leawood 13
London 13
Auburn Hills 11
Cambridge 11
Bolzano 10
Boydton 10
Kemerovo 10
San Diego 10
Tappahannock 10
Turin 10
Brescia 9
Clearwater 9
Miami 9
Philadelphia 9
Timisoara 9
Ardabil 8
Florianópolis 8
Greifswald 8
Madrid 8
Montréal 8
Novokuznetsk 8
Phoenix 8
Saint Louis 8
San Mateo 8
Bari 7
Totale 21.210
Salva come PNG Salva come JPEG
Nome #
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 371
Epidemiology and Economic Burden of Osteoporosis in Italy 294
Teriparatide and denosumab combination therapy and skeletal metabolism 243
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 219
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 168
Artrite Reumatoide e Metabolismo Minerale 163
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 145
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 138
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 133
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 131
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 127
Incidenza di ipovitaminosi D nel Nord Italia 127
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 127
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 127
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 119
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 118
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 114
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 113
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 113
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 113
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 112
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 112
Rapporti tra sistema immune e metabolismo osseo 111
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 110
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 109
DXA bone mineral density in males: retrospective study in real life. 108
Prevalence and incidence of rheumatoid arthritis in Italy. 108
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 108
Bone metabolism in patients with anorexia nervosa and amenorrhoea 108
[Therapeutic strategies in osteoporosis: whom and when to treat] 107
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 106
Age-related bone loss in postmenopausal women 106
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 105
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 104
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 102
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 102
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 102
The renal handling of calcium: influence of parathyroid hormone secretion 101
Osteopetrosi 101
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 101
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 100
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 100
Osteoporosis treatment: why ibandronic acid? 100
Guidelines for the diagnosis, prevention and management of osteoporosis 100
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 100
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 98
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 98
Anti-CCP antibodies and bone 98
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 98
Vitamin D levels in patients with psoriasis with or without arthritis 97
Prevalence of osteoporosis in patients affected by mastocytosis 97
Incidenza di ipovitaminosi D nel Nord Italia 96
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 96
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 96
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 95
Anabolic steroids in corticosteroid-induced osteoporosis 94
Osteoporosi: progressi nella diagnosi e nel trattamento 94
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 94
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 94
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 94
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 93
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 93
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 93
Bone turnover markers in patients with osteogenesis imperfecta 91
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 91
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 91
Bone turnover markers in patients with osteogenesis imperfecta. 91
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 91
Safety issues and adverse reactions with osteoporosis management 91
Could γ\δ T-cells explain zoledronic acid adverse events? 91
The initiative on hip fractures of the Veneto Region 90
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 90
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 89
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 88
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 88
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 88
The radiological assessment of vertebral osteoporosis 87
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 87
Drug-induced osteonecrosis of the jaw: the state of the art 87
Peak bone mass and peak bone density. 87
The radiological assessment of vertebral osteoporosis 85
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 85
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 85
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 85
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 85
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 85
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 85
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 84
Osteoporisis costs in Italy: interim results of the block study 84
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 84
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 84
Duration of treatment for osteoporosis 84
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 84
Hypercalcemia of malignancy: pathophysiology and treatment 84
Transdermal Estradiol in the treatment of postmenopausale bone loss. 83
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 83
Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study. 83
Bone involvement in patient with clonal mast cell disorders 83
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 83
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 83
Totale 10.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.846
article - articoli 102.006
book - libri 0
conference - conferenze 1.592
curatela - curatele 0
other - altro 242
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.006
Totale 213.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.122 0 44 32 364 427 395 359 369 198 321 139 474
2020/20213.886 427 729 113 436 497 426 82 243 307 27 441 158
2021/20223.278 240 811 49 158 156 128 61 185 279 97 305 809
2022/20236.844 562 555 704 1.182 607 1.654 87 384 733 75 226 75
2023/20243.519 179 270 330 419 404 534 181 274 58 128 496 246
2024/2025917 564 353 0 0 0 0 0 0 0 0 0 0
Totale 31.219